246 related articles for article (PubMed ID: 31142771)
1. Interplay of fibroblasts with anaplastic tumor cells promotes follicular thyroid cancer progression.
Fozzatti L; Alamino VA; Park S; Giusiano L; Volpini X; Zhao L; Stempin CC; Donadio AC; Cheng SY; Pellizas CG
Sci Rep; 2019 May; 9(1):8028. PubMed ID: 31142771
[TBL] [Abstract][Full Text] [Related]
2. Tumor Cells and Cancer-Associated Fibroblasts: A Synergistic Crosstalk to Promote Thyroid Cancer.
Fozzatti L; Cheng SY
Endocrinol Metab (Seoul); 2020 Dec; 35(4):673-680. PubMed ID: 33161690
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast-mediated in vivo and in vitro growth promotion of tumorigenic rat thyroid carcinoma cells but not normal Fisher rat thyroid follicular cells.
Saitoh O; Mitsutake N; Nakayama T; Nagayama Y
Thyroid; 2009 Jul; 19(7):735-42. PubMed ID: 19485776
[TBL] [Abstract][Full Text] [Related]
4. Heterotypic paracrine signaling drives fibroblast senescence and tumor progression of large cell carcinoma of the lung.
Lugo R; Gabasa M; Andriani F; Puig M; Facchinetti F; Ramírez J; Gómez-Caro A; Pastorino U; Fuster G; Almendros I; Gascón P; Davalos A; Reguart N; Roz L; Alcaraz J
Oncotarget; 2016 Dec; 7(50):82324-82337. PubMed ID: 27384989
[TBL] [Abstract][Full Text] [Related]
5. Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin.
Fallahi P; Ferrari SM; Elia G; Ragusa F; Patrizio A; Paparo SR; Marone G; Galdiero MR; Guglielmi G; Foddis R; Cristaudo A; Antonelli A
Semin Cancer Biol; 2022 Feb; 79():203-216. PubMed ID: 32569821
[TBL] [Abstract][Full Text] [Related]
6. Stromal-epithelial crosstalk provides a suitable microenvironment for the progression of ovarian cancer cells in vitro.
Fu S; Dong L; Sun W; Xu Y; Gao L; Miao Y
Cancer Invest; 2013 Nov; 31(9):616-24. PubMed ID: 24147897
[TBL] [Abstract][Full Text] [Related]
7. Tumoral microvesicle-activated glycometabolic reprogramming in fibroblasts promotes the progression of oral squamous cell carcinoma.
Jiang E; Xu Z; Wang M; Yan T; Huang C; Zhou X; Liu Q; Wang L; Chen Y; Wang H; Liu K; Shao Z; Shang Z
FASEB J; 2019 Apr; 33(4):5690-5703. PubMed ID: 30698991
[TBL] [Abstract][Full Text] [Related]
8. Reciprocal activation of cancer-associated fibroblasts and oral squamous carcinoma cells through CXCL1.
Wei LY; Lee JJ; Yeh CY; Yang CJ; Kok SH; Ko JY; Tsai FC; Chia JS
Oral Oncol; 2019 Jan; 88():115-123. PubMed ID: 30616781
[TBL] [Abstract][Full Text] [Related]
9. Cytologic features of aggressive variants of follicular-derived thyroid carcinoma.
Rossi ED; Faquin WC; Pantanowitz L
Cancer Cytopathol; 2019 Jul; 127(7):432-446. PubMed ID: 31150164
[TBL] [Abstract][Full Text] [Related]
10. Mouse Model of Thyroid Cancer Progression and Dedifferentiation Driven by STRN-ALK Expression and Loss of p53: Evidence for the Existence of Two Types of Poorly Differentiated Carcinoma.
Nikitski AV; Rominski SL; Condello V; Kaya C; Wankhede M; Panebianco F; Yang H; Altschuler DL; Nikiforov YE
Thyroid; 2019 Oct; 29(10):1425-1437. PubMed ID: 31298630
[No Abstract] [Full Text] [Related]
11. Cell competition between anaplastic thyroid cancer and normal thyroid follicular cells exerts reciprocal stress response defining tumor suppressive effects of normal epithelial tissue.
Amrenova A; Suzuki K; Saenko V; Yamashita S; Mitsutake N
PLoS One; 2021; 16(4):e0249059. PubMed ID: 33793628
[TBL] [Abstract][Full Text] [Related]
12. Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET/PTC1 Rearrangement, BRAFV600E, or RASQ61R as Drivers.
Schweppe RE; Pozdeyev N; Pike LA; Korch C; Zhou Q; Sams SB; Sharma V; Pugazhenthi U; Raeburn C; Albuja-Cruz MB; Reigan P; LaBarbera DV; Landa I; Knauf JA; Fagin JA; Haugen BR
Mol Cancer Res; 2019 May; 17(5):1036-1048. PubMed ID: 30733375
[TBL] [Abstract][Full Text] [Related]
13. Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts.
Kaminski A; Hahne JC; Haddouti el-M; Florin A; Wellmann A; Wernert N
Int J Mol Med; 2006 Nov; 18(5):941-50. PubMed ID: 17016625
[TBL] [Abstract][Full Text] [Related]
14. The sonic hedgehog signaling pathway stimulates anaplastic thyroid cancer cell motility and invasiveness by activating Akt and c-Met.
Williamson AJ; Doscas ME; Ye J; Heiden KB; Xing M; Li Y; Prinz RA; Xu X
Oncotarget; 2016 Mar; 7(9):10472-85. PubMed ID: 26859575
[TBL] [Abstract][Full Text] [Related]
15. Interaction with adipocyte stromal cells induces breast cancer malignancy via S100A7 upregulation in breast cancer microenvironment.
Sakurai M; Miki Y; Takagi K; Suzuki T; Ishida T; Ohuchi N; Sasano H
Breast Cancer Res; 2017 Jun; 19(1):70. PubMed ID: 28629450
[TBL] [Abstract][Full Text] [Related]
16. Expression of MicroRNAs in Thyroid Carcinoma.
Zhu G; Xie L; Miller D
Methods Mol Biol; 2017; 1617():261-280. PubMed ID: 28540691
[TBL] [Abstract][Full Text] [Related]
17. SAHA-induced loss of tumor suppressor Pten gene promotes thyroid carcinogenesis in a mouse model.
Zhu X; Kim DW; Zhao L; Willingham MC; Cheng SY
Endocr Relat Cancer; 2016 Jul; 23(7):521-33. PubMed ID: 27267120
[TBL] [Abstract][Full Text] [Related]
18. Activation of fibroblasts by nicotine promotes the epithelial-mesenchymal transition and motility of breast cancer cells.
Chen PC; Lee WY; Ling HH; Cheng CH; Chen KC; Lin CW
J Cell Physiol; 2018 Jun; 233(6):4972-4980. PubMed ID: 29215705
[TBL] [Abstract][Full Text] [Related]
19. The tumor microenvironment promotes cancer progression and cell migration.
Salvatore V; Teti G; Focaroli S; Mazzotti MC; Mazzotti A; Falconi M
Oncotarget; 2017 Feb; 8(6):9608-9616. PubMed ID: 28030810
[TBL] [Abstract][Full Text] [Related]
20. Metformin blocks progression of obesity-activated thyroid cancer in a mouse model.
Park J; Kim WG; Zhao L; Enomoto K; Willingham M; Cheng SY
Oncotarget; 2016 Jun; 7(23):34832-44. PubMed ID: 27145454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
